Table 2. Patient-reported outcomes in patients with SSc.
| Limited cutaneous SSc (n=115) | Diffuse cutaneous SSc (n=141) | Total SSc group (n=256) | p | ||||
| Median | Range | Median | Range | Median | Range | ||
| Patient rated cutaneous activity (VAS) | 3 | 0-10 | 7 | 0-10 | 5 | 0-10 | <0.001 |
| Patient rated RP activity (VAS) | 3 | 0-10 | 5 | 0-10 | 5 | 0-10 | <0.001 |
| Patient rated digital ulcer activity (VAS) | 0 | 0-10 | 2 | 0-8 | 0 | 0-10 | <0.001 |
| Pain (VAS) | 4 | 0-10 | 5 | 0-10 | 5 | 0-10 | <0.001 |
| HAQ | 0.45 | 0-2.05 | 0.75 | 0-2.05 | 0.55 | 0-2.05 | 0.001 |
| SHAQ | 0.6 | 0-2.2 | 1 | 0-2.40 | 0.80 | 0-2.4 | <0.001 |
| DHI total score | 8.5 | 0-62 | 23 | 0-72 | 15 | 0-72 | 0.001 |
| SF-36 PCS | 52.81 | 2.5-93.75 | 40.94 | 9.37-92.5 | 47.5 | 2.5-93.75 | 0.001 |
| SF-36 MCS | 51.04 | 0-90.5 | 38.62 | 6.25-90.75 | 42.83 | 0-90.75 | 0.007 |
| SSc: Systemic sclerosis; VAS: Visual Analog Scale; RP: Raynaud phenomenon; HAQ: Health Assessment Questionnaire; SHAQ: Scleroderma HAQ; DHI: Duruöz Hand Index; SF-36: Short form 36; PCS: Physical Component Score; MCS: Mental Component Score. | |||||||